Acetyl‐L‐carnitine for the treatment of diabetic peripheral neuropathy

Background Diabetic peripheral neuropathy (DPN) is a common and severe complication that affects 50% of people with diabetes. Painful DPN is reported to occur in 16% to 24% of people with diabetes. A complete and comprehensive management strategy for the prevention and treatment of DPN, whether pain...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cochrane database of systematic reviews 2019-06, Vol.2019 (6), p.CD011265
Hauptverfasser:	Rolim, Luiz CSP, da Silva, Edina MK, Flumignan, Ronald LG, Abreu, Marcio M, Dib, Sérgio A
Format:	Artikel
Sprache:	eng
Schlagworte:	Acetylcarnitine Acetylcarnitine - administration & dosage Acetylcarnitine - adverse effects Acetylcarnitine - therapeutic use Acetyl‐L‐carnitine Adult Aged Complementary & alternative medicine Diabetes Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 1 - complications Diabetes Mellitus, Type 2 Diabetes Mellitus, Type 2 - complications Diabetes‐related Diabetic Neuropathies Diabetic Neuropathies - complications Diabetic Neuropathies - drug therapy Diabetic neuropathy Diabetic peripheral neuropathy Endocrine & metabolic Female Humans Male Medicine General & Introductory Medical Sciences Middle Aged Neuralgia Neuralgia - drug therapy Neurology Pain Measurement Peripheral Neuropathy Pharmacological treatment Placebos Placebos - therapeutic use Randomized Controlled Trials as Topic Sensation Sensation - drug effects Vibration Vitamin B 12 Vitamin B 12 - administration & dosage Vitamin B 12 - analogs & derivatives Vitamin B 12 - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!